ADURO BIOTECH, INC. Note Agreements
3 Contracts & Agreements
- Note Termination Agreement, dated August 17, 2020, by and among Aduro Biotech, Inc., Chinook Therapeutics U.S., Inc. and certain investors named therein (Filed With SEC on August 18, 2020)
- Form of Convertible Promissory Note (Filed With SEC on June 2, 2020)
- Note Purchase Agreement, dated as of June 1, 2020, by and among Chinook Therapeutics U.S., Inc. and certain investors named therein (Filed With SEC on June 2, 2020)
